Developer gets up to $2M in incentives for Alamo Heights office © 2026 American City Business Journals. All rights reserved.
The combined company will operate as Obsidian Therapeutics following the merger. Investors in the $350 million private ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results